ENTX

Entera Bio Ltd. Ordinary Shares

$1.27 -5.93%

Recent alerts on ENTX

All signals →

News Stock Market Today: S&P 500, Dow Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'—Palantir, Rezolve AI, Entera Bio In Focus

News Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'— PLTR, RZLV, ENTX In Focus (UPDATED)

News Entera Bio Beats Q2 EPS Estimates

News AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

News Ultragenyx (RARE) DTX401 Meets Goals in Metabolic Disorder Study

News AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal

News Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus

News Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data

News Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

News Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

News Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

News Sanofi (SNY) Signs Deal for AI-Powered Drug Development

News Entera Bio GAAP EPS of -$0.07 beats by $0.02

Insider trade Purchase by Geno J Germano

Insider trade Purchase by Sean Ellis

Insider trade Purchase by Steven D Rubin

Insider trade Purchase by Sean Ellis

Insider trade Purchase by Steven D Rubin

Insider trade Purchase by Geno J Germano

Insider trade Purchase by Haya Taitel

News Blackstone to Lead $600 Million Investment in AI Firm Neysa

SEC filing ENTX Appoints Geno J. Germano as Chairman, Aims to Advance EB613 and Other Oral Peptide Programs in 2026

Scanner Unusual volume (2.1x average)

Get push alerts for ENTX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS